Status:
UNKNOWN
Large-scale COVID-19 Population Screening
Lead Sponsor:
Hong Kong University of Science and Technology
Collaborating Sponsors:
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Infectious diseases pose a threat to the life of individuals worldwide. The pandemic has highlighted the need to develop an innovative and cost- effective large population-based screening methodology....
Detailed Description
Rapid host-to-host transmissions coupled with the ease of international travel has led to epidemics such as H5N1, H5N5, SARS, and, most recently, the COVID-19 pandemic. Traditional epidemic control me...
Eligibility Criteria
Inclusion
- Patients hospitalized at the Prince of Wales Hospital who have received testing for SARS-CoV-2 PCR
- Age 18 years or above
Exclusion
- Mentally incompetent to provide informed consent
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04847804
Start Date
July 1 2021
End Date
May 31 2024
Last Update
March 1 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong University of Sciences and Technology
Sai Kung, Hong Kong
2
Chinese University of Hong Kong
Shatin, Hong Kong
3
Prince of Wales Hospital
Shatin, Hong Kong